New legislation published today to bring faster response to new drugs in Europe

News

New legislation published today to bring faster response to new drugs in Europe

23 November 2017
European Monitoring Centre on Drugs and Drug Addiction (EMCDDA)

By European Monitoring Centre for Drugs and Drug Addiction

Europe’s ability to rapidly respond to public health and security threats caused by new psychoactive substances (NPS) will be significantly strengthened, thanks to new legislation published today by the European Union (1).

The legislation includes a stronger EU Early Warning System (EWS) and a faster risk-assessment process. The developments are in response to the recent growth in the market in NPS and follow a proposal from the European Commission (EC) comprising:

  • Regulation regarding information exchange on, and an early-warning system and risk-assessment procedure for, new psychoactive substances (amending the EMCDDA founding regulation); and
  • Directive including new psychoactive substances in the definition of ‘drug’.

Click here to read the full article.

Thumbnail: CC EU

Related Profiles

  • European Monitoring Centre on Drugs and Drug Addiction (EMCDDA)

Translations